ArticlePigment cell & melanoma research2025

Low-Dose Baricitinib Plus Narrow-Band Ultraviolet B for the Treatment of Progressive Non-Segmental Vitiligo: A Prospective, Controlled, Open-Label Study.

Zhonghui Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.